FTC Makes Example Of Perrigo, Alpharma In Disgorgement Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Trade Commission's $6.25 mil. settlement with Perrigo, Alpharma represents first use of the agency's disgorgement policy. The settlement appears to establish legal precedent barring agreements between firms seeking first-filer status for an ANDA.
You may also be interested in...
Savient Delays 10-Q Filing Due To Oxandrin Return Reserve Errors
The firm will restate first quarter and 2004 year-end results due to less-than-expected returns of the anabolic agent.
P&G/Sanofi Combine Actonel With Calcium In 28-Day Regimen
FDA approves bisphosphonate line extension featuring four days of risedronate dosing and 24 days of calcium supplementation.
USP Advisory Group To Evaluate International Harmonization Efforts
A committee comprising stakeholders will discuss ways of improving USP's work with international pharmacopeias to harmonize excipient monographs and general chapters.